The phase 3 pediatric anticoagulant era

Neil A. Goldenberg; Brian R. Branchford

doi:10.1182/blood.2019004340

The phase 3 pediatric anticoagulant era

Neil A. Goldenberg, Brian R. Branchford

School of Medicine

Research output: Contribution to journal › Review article › peer-review

2 Scopus citations

Abstract

In

Original language	English (US)
Pages (from-to)	459-460
Number of pages	2
Journal	Blood
Volume	135
Issue number	7
DOIs	https://doi.org/10.1182/blood.2019004340
State	Published - Feb 13 2020

ASJC Scopus subject areas

Biochemistry
Immunology
Hematology
Cell Biology

Access to Document

10.1182/blood.2019004340

Cite this

@article{0c15b0b7f3ab46d2b50d2fff0556b691,

title = "The phase 3 pediatric anticoagulant era",

abstract = "In",

author = "Goldenberg, {Neil A.} and Branchford, {Brian R.}",

note = "Funding Information: Conflict-of-interest disclosure: N.A.G. receives salary and research support from the National Institutes of Health and consultancy fees from Chiesi, Daiichi Sankyo Inc., Novartis, and the University of Colorado–affiliated Academic Research Organization CPC Clinical Research. B.R.B. declares no competing fi-nancial interests. n Publisher Copyright: {\textcopyright} 2020 by The American Society of Hematology",

year = "2020",

month = feb,

day = "13",

doi = "10.1182/blood.2019004340",

language = "English (US)",

volume = "135",

pages = "459--460",

journal = "Blood",

issn = "0006-4971",

publisher = "American Society of Hematology",

number = "7",

}

TY - JOUR

T1 - The phase 3 pediatric anticoagulant era

AU - Goldenberg, Neil A.

AU - Branchford, Brian R.

N1 - Funding Information: Conflict-of-interest disclosure: N.A.G. receives salary and research support from the National Institutes of Health and consultancy fees from Chiesi, Daiichi Sankyo Inc., Novartis, and the University of Colorado–affiliated Academic Research Organization CPC Clinical Research. B.R.B. declares no competing fi-nancial interests. n Publisher Copyright: © 2020 by The American Society of Hematology

PY - 2020/2/13

Y1 - 2020/2/13

N2 - In

AB - In

UR - http://www.scopus.com/inward/record.url?scp=85079609163&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85079609163&partnerID=8YFLogxK

U2 - 10.1182/blood.2019004340

DO - 10.1182/blood.2019004340

M3 - Review article

C2 - 32197268

AN - SCOPUS:85079609163

SN - 0006-4971

VL - 135

SP - 459

EP - 460

JO - Blood

JF - Blood

IS - 7

ER -

The phase 3 pediatric anticoagulant era

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this